Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
4.410
-0.010 (-0.23%)
Nov 20, 2024, 4:00 PM EST - Market closed
Humacyte Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Revenue | - | - | 1.57 | 1.26 | 1.49 | 6.19 |
| Revenue Growth (YoY) | - | - | 23.91% | -15.29% | -75.90% | - |
| Cost of Revenue | 77.4 | 76.55 | 63.26 | 61.34 | 54.08 | 75.6 |
| Gross Profit | -77.4 | -76.55 | -61.7 | -60.08 | -52.59 | -69.42 |
| Selling, General & Admin | 24.37 | 20.39 | 22.88 | 21.13 | 12.01 | 16.28 |
| Operating Expenses | 35.09 | 20.39 | 22.88 | 21.13 | 12.01 | 16.28 |
| Operating Income | -112.49 | -96.94 | -84.58 | -81.21 | -64.6 | -85.69 |
| Interest Expense | -8.5 | -6.6 | -6.2 | -4.35 | -2.2 | -2.3 |
| Interest & Investment Income | 4.4 | 5.47 | 2.63 | 0.02 | 0.28 | 2.57 |
| Other Non Operating Income (Expenses) | 0.69 | -0.26 | 0.42 | 0.06 | - | - |
| EBT Excluding Unusual Items | -115.9 | -98.33 | -87.73 | -85.48 | -66.52 | -85.42 |
| Merger & Restructuring Charges | - | - | - | -0.05 | - | - |
| Other Unusual Items | -36.97 | -12.44 | 75.77 | 59.06 | - | - |
| Pretax Income | -152.87 | -110.78 | -11.97 | -26.48 | -66.52 | -85.42 |
| Net Income | -152.87 | -110.78 | -11.97 | -26.48 | -66.52 | -85.42 |
| Net Income to Common | -152.87 | -110.78 | -11.97 | -26.48 | -66.52 | -85.42 |
| Shares Outstanding (Basic) | 113 | 103 | 103 | 40 | 6 | 20 |
| Shares Outstanding (Diluted) | 113 | 103 | 103 | 40 | 6 | 20 |
| Shares Change (YoY) | 9.01% | 0.36% | 157.82% | 593.25% | -71.34% | - |
| EPS (Basic) | -1.36 | -1.07 | -0.12 | -0.66 | -11.54 | -4.25 |
| EPS (Diluted) | -1.36 | -1.07 | -0.12 | -0.66 | -11.54 | -4.25 |
| Free Cash Flow | -92.26 | -75.59 | -72.18 | -81.41 | -55.89 | -79.91 |
| Free Cash Flow Per Share | -0.82 | -0.73 | -0.70 | -2.04 | -9.69 | -3.97 |
| Operating Margin | - | - | -5404.35% | -6429.77% | -4332.66% | -1385.02% |
| Profit Margin | - | - | -764.54% | -2096.36% | -4461.70% | -1380.67% |
| Free Cash Flow Margin | - | - | -4611.95% | -6445.76% | -3748.22% | -1291.61% |
| EBITDA | -105.28 | -89.22 | -76.37 | -72.97 | -56.25 | -78.94 |
| D&A For EBITDA | 7.22 | 7.72 | 8.21 | 8.24 | 8.35 | 6.75 |
| EBIT | -112.49 | -96.94 | -84.58 | -81.21 | -64.6 | -85.69 |
Source: S&P Capital IQ. Standard template.
Financial Sources.